
Infis AI helps pharmaceutical and manufacturing companies reduce supplier risk and improve supply chain resilience. The platform uses AI to connect fragmented data from ERPs, emails, and external sources like geopolitical events and tariff changes. Infis continuously monitors suppliers, generates a clear risk score out of 10, and automates mitigation steps such as alternative sourcing recommendations.

Infis AI helps pharmaceutical and manufacturing companies reduce supplier risk and improve supply chain resilience. The platform uses AI to connect fragmented data from ERPs, emails, and external sources like geopolitical events and tariff changes. Infis continuously monitors suppliers, generates a clear risk score out of 10, and automates mitigation steps such as alternative sourcing recommendations.
Sector: AI-powered supplier risk management for pharma and manufacturing
Headquarters: San Francisco, CA
Stage / Funding: Pre-Seed (one disclosed round, Oct 9, 2024)
Founders: Prayas Tiwari
Employees: 4
Supplier risk, supply-chain resilience, GMP/compliance and material shortage detection for pharma and manufacturing.
2024
Supply chain / Risk management / Pharmaceutical manufacturing software
Round listed with participation from NEC X and Alchemist Accelerator
“NEC X; Alchemist Accelerator”